Facilitating Access to Approved Medication

omacetaxine mepesuccinate Injection
omacetaxine mepesuccinate for Injection is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI). This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with omacetaxine mepesuccinate.

Get Access To omacetaxine mepesuccinate Injection

Ribociclib-tablets Available Price In India UK Saudi Arabia

Omacetaxine Mepesuccinate Injection

  • API: omacetaxine mepesuccinate
  • Packaging: Injection
  • Strength: Single-use vial containing 3.5 mg of omacetaxine mepesuccinate as a lyophilized powder.


The US Food and Drug Administration (FDA) approved omacetaxine mepesuccinate for the treatment of adults with chronic myelogenous leukemia (CML) who are resistant to other therapies. The new drug is intended for patients whose cancer has progressed following treatment with at least two tyrosine kinase inhibitors (TKIs).


All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.